Bass, Berry & Sims attorney Danielle Sloane commented for an article outlining the impact of the Trump administration’s withdrawal of a proposed program integrity final rule related to healthcare fraud enforcement. This rule was intended to implement Section 6401 of the Affordable Care Act and in essence aimed to allow government healthcare programs to see through corporate structures to individual bad actors and hold not just the offending company liable, but any company affiliated with those individuals.

The full article, “Health Fraud Rule Withdrawal May Hurt Enforcement Efforts,” was published by BNA’s Health Care Daily Report on February 1, 2017.